|
Medtronic received information that during use of a mc3 nautilus extracorporeal membrane oxygenation (ecmo) oxygenator, a blood leak was observed from the oxygenator arterial blood outlet port component, reportedly not associated with the tubing connected to the port.Patient blood loss occurred; the amount was unavailable.The device was replaced to complete the case.There was no adverse patient effect associated with this event.
|
|
Device evaluation: visual inspection showed evidence of a crack in the outer housing.Additional visual inspection showed a leak path in the bond connection under the qb-outlet port assembly.Pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there was a leak observed from the qb-outlet port assembly.Conclusion: reason for the return was confirmed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|